Determining the relevance of this ATF4-FGF21 axis in BAT physiology and BAT-mediated metabolic adaptations may lead to novel therapeutic approaches to combat obesity and associated disorders. This evidence concerns the gene ATF4 and obesity due to melanocortin 4 receptor deficiency.